Solution
Industries
Resources
About
Beacon Search

Drug-device Combinations: The Global Market

Report Code: PHM045B

Publish Date: Jan 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Overall sales of drug device combination products were $12 billion in 2008 and $13.7 billion in 2009. This is projected to reach  $27 billion in 2014 at a compound annual growth rate (CAGR) of 14.5%
  • Sales in coronary stents Products were nearly $4.4 billion in 2008 and $4.8 billion in 2009. This market is projected to reach $7.4 billion in 2014, for a 5-year CAGR of 9%.
  • Photodynamic therapies market was $1.3 billion in 2008, which increased slightly in 2009 to $1.5 billion. This market is projected to reach approx $2.6 billion in 2014, for a 5-year CAGR of 11.6%.

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
This report discusses key markets for drug device combination products. It provides descriptions of technologies and products, a review of the status of R&D initiatives and a forecast of the market through 2014. Company profiles and a patent analysis are provided as well. Example product categories that are covered include drug-eluting stents (DES), drug-eluting beads (DEB), antimicrobial catheters, antibiotic-loaded bone cements, glass ionomer cements, bone graft substitutes, antibacterial releasing dental restorative materials, biologic wound care products such as collagen-based dressings as therapeutic agents for wound healing, drug device combination products for ocular applications, photodynamic therapy, and other important niches. 
  
REASONS FOR DOING THIS STUDY AND ITS IMPORTANCE
 
Products that combine a drug or biologic with a device, such as drug-eluting stents and drug-delivery systems, can offer valuable approaches for treating diseases. In addition, developments in cell-based therapeutics, progenitor cell exploitation, growth factor delivery and advanced formulation strategies are becoming the basis of even more advanced combination device strategies. Technology advancements in the drug device combination market have been of considerable import in recent years and the pace of activity seems to be quickening with the appearance of many development-stage companies.
 
Especially since the approval of Johnson & Johnson’s Cypher drug-eluting stent in 2003 and Boston Scientific’s Taxus drug-eluting stent in 2004, drug-device combination products have attracted significant medical and media attention. But, combination products are subject to intense regulatory scrutiny for the issues of safety and effectiveness. Teams of device and drug product reviewers at a number of FDA centers are dedicated to evaluating such products. Thus, the bar is very high for FDA product approvals and consequently some combination products in certain categories are very small in number. For example, the entire fibrin sealant market is shared by only five FDA-approved products. Beyond drug-eluting stents and other categories noted above, combination products subject to FDA scrutiny include innovative drug-delivery systems, hemostatic sealants, photodynamic-therapy systems, gene-therapy systems, and products for many other investigational treatments.
 
The development of the market for combination products is closely related to another dynamic and fast growing healthcare segment generally termed “drug-delivery systems”. “Delivery systems” represents a vast area of research and development within biomaterials and medicine and the demand for sophisticated drug-delivery devices is behind many novel product developments. Advanced drug-delivery devices offer increased efficiency, improved performance and convenience.
 
INTENDED AUDIENCE
 
With its broad scope and in-depth analyses, this study will prove to be a valuable resource, particularly for anyone involved with or interested in the future of the fast growing drug device combination market. This study will be particularly useful for researchers, laboratory and government personnel working in research or company settings, as well as business professionals involved with drug and device development. It also will be of value to potential investors and members of the general public interested in acquiring a business-oriented view of a key health care sector in the economy. The projections, forecasts, and trend analyses found in this report provide readers with the necessary data and information for decision-making.
 
SCOPE AND FORMAT OF REPORT
 
In preparing this report, an overall study of the drug device combination market was undertaken. Related areas, such as drug delivery systems and nanotechnology, were key to the analysis as well, as newer areas such as nanotechnology, foreshadow likely product developments in the years ahead. All major aspects of the drug device combination market are addressed including identification of current and future technologies, products, market segments/end markets, and government and regulatory agencies. Participating companies are discussed in light of technological strengths and weakness, relative market share, marketing strengths, and innovative marketing practices. Included is a detailed discussion of the current regulatory environment for drug-device combination products and how this is affecting development and approval of such products.
 
METHODOLOGY AND INFORMATION SOURCES
 
Data for this study were collected using both primary and secondary data research techniques. A literature search was conducted covering scientific, medical, business and technical documents, as well as patents. Since most segments of the drug device combination market are not routinely measured, BCC derived estimates from a variety of sources. Whenever market estimates are derived, they are fully noted. All forecasts are in current (nominal) dollars, unadjusted for inflation. 
 
ANALYST CREDENTIALS
 
Research analyst Kevin Gainer holds both B.A. and M.A. degrees in quantitative economic analysis and has 25 years of economic, industry intelligence and market research experience. He is the author of six published books and dozens of technical papers, analyses, and studies published in conference proceedings, including many unpublished within corporations. He has worked as a Research Editor and Project Analyst at BCC Research since 1985, and has authored numerous BCC technology market research reports.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
 
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Drug-device Combinations: The Global Market244Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY4Free
Chapter- 3: CURRENT STATUS OF THE DRUG DEVICE COMBINATION INDUSTRY9Free
Chapter- 4: REGULATORY PROCESS AND ISSUES7Free
Chapter- 5: NANOTECH COMBINATION PRODUCTS17Free
Chapter- 6: DRUG-ELUTING CORONARY STENTS15Free
Chapter- 7: PHOTODYNAMIC THERAPY12Free
Chapter- 8: ANTIMICROBIALS AND OTHER MEDICAL DEVICE COATINGS8Free
Chapter- 9: ANTIMICROBIAL CATHETERS8Free
Chapter- 10: DRUG-ELUTING BEADS14Free
Chapter- 11: BONE CEMENTS INCLUDING ANTIBIOTIC9Free
Chapter- 12: BONE GRAFT SUBSTITUTES39Free
Chapter- 13: WOUND CARE PRODUCTS INCLUDING BIOLOGICAL DRESSINGS 14Free
Chapter- 14: DRUG DEVICE COMBINATION PRODUCTS FOR OCCULAR APPLICATIONS7Free
Chapter- 15: IMPLANTABLES AS DRUG DEVICE COMBINATIONS4Free
Chapter- 16: RELATED DRUG DEVICE COMBINATIONS OF RELEVANCE10Free
Chapter- 17: PATENT ANALYSIS17Free
Chapter- 18: INDUSTRY STRUCTURE AND COMPANY PROFILES42Free
Chapter- 19: APPENDIX4Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 36

  • Summary Table: SALES OF DRUG DEVICE COMBINATION PRODUCTS, THROUGH 2014
  • Table 1: RECENT EXAMPLES OF FDA APPROVED COMBINATION PRODUCTS
  • Table 2: FDA CLASSIFICATION SCHEME FOR COMBINATION PRODUCTS
  • Table 3: FDA COMBINATION PRODUCT CATEGORIES, FY 2004
  • Table 4: FDA COMBINATION PRODUCT CATEGORIES, FY 2005
  • Table 5: REVENUES ATTRIBUTABLE TO NANOTECHNOLOGY-BASED DRUG-DEVICE COMBINATIONS, THROUGH 2014
  • Table 6: MARKETS FOR CORONARY STENTS, THROUGH 2014
  • Table 7: EXAMPLES OF STENTS APPROVED FOR CLINICAL USE
  • Table 8: PHOTODYNAMIC THERAPY MARKETS, THROUGH 2014
  • Table 9: REVENUES ATTRIBUTABLE TO ANTIMICROBIALS THROUGH 2014
  • Table 10: REVENUES ATTRIBUTABLE TO MEDICAL DEVICE COATINGS THROUGH 2014
Sample Report

Recent Reports

Global GLP-1 Analogues Market

Published - Dec 2025 | Publisher - BCC Publishing | Code - PHM289A

This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025–2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

Immunotherapy Drugs: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - PHM249B

The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.

Global Artificial Intelligence (AI) in Clinical Trials Market

Published - Oct 2025 | Publisher - BCC Publishing | Code - PHM285A

The global market for Artificial Intelligence (AI) in Clinical Trials was valued at $2 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $6.5 billion by 2030, at a compound annual growth rate (CAGR) of 22.6% from 2025 through 2030.

Brain Tumor Therapeutics: Global Markets to 2030

Published - Oct 2025 | Publisher - BCC Publishing | Code - PHM208B

The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.

Global Viral Vector Manufacturing Markets and Technologies Through 2030

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM172B

The global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.

Top Trending Reports

Global Data Center Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - IFT320A

The global market for data centers is expected to grow from $418.2 billion in 2025 and is projected to reach $691.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

Contract Manufacturing of Medical Devices: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - MDS039B

The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from 2025 to 2030.

Bioprocess Filtration: Global Markets

Published - Oct 2025 | Publisher - BCC Publishing | Code - MDS043B

The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to reach $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.

Biological Therapies for Cancer: Technologies and Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO048E

The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.

Immunotherapy Drugs: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - PHM249B

The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.

Published - Jun-2005| Analyst - Lynn Gray| Code - PHM045A

Report Highlights

  • The total market for drug-device combinations worldwide was valued at $5.4 billion in 2004 and is expected to rise at an average annual growth rate (AAGR) of 13.6% to $11.5 billion in 2010.
  • The star category is drug-eluting stents that will continue to show average annual growth of 11.5%. This will result in the market doubling to $8 billion in 2010.
  • With the exception of bone graft substitutes and antibiotic bone cements, all categories will show double-digit growth.
  • The U.S. dominates the market for drug-device combination products, mainly because the largest-selling drug-eluting stents have been enthusiastically accepted in this market and consequently are penetrating the market more quickly than in Europe.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Drug-device Combinations: The Global Market
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment